Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hogan

Showing results (141-150 of 153) with videos related to

Pageof 16
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 13, 2004
Preventing the spontaneous modification of an HLA-A2-restricted peptide at an N-terminal glutamine or an internal cysteine residue enhances peptide antigenicityLee W Thompson, Kevin T Hogan, Jennifer A Caldwell, et al.
Chempluschem|January 17, 2020
Synthesis of Oligo(1,8-pyrenylene)s: A Series of Functional Molecular LiquidsJoshua C Walsh, David T Hogan, Kerry-Lynn M Williams, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 9, 2008
A multipeptide vaccine is safe and elicits T-cell responses in participants with advanced stage ovarian cancerKimberly A Chianese-Bullock, William P Irvin, Gina R Petroni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Genomic organization, incidence, and localization of the SPAN-x family of cancer-testis antigens in melanoma tumors and cell linesV Anne Westbrook, Pamela D Schoppee, Alan B Diekman, et al.
Annals of Surgical Oncology|October 17, 2008
Evaluation of the sentinel immunized node for immune monitoring of cancer vaccinesCraig L Slingluff, Galina V Yamshchikov, Kevin T Hogan, et al.
Leukemia & Lymphoma|January 21, 2017
A phase 1 study of bortezomib and romidepsin in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma, indolent B-cell lymphoma, peripheral T-cell lymphoma, or cutaneous T-cell lymphomaBeata Holkova, Victor Yazbeck, Maciej Kmieciak, et al.
Scientific Reports|February 27, 2024
The Tehran longitudinal family-based cardiometabolic cohort study sheds new light on dyslipidemia transmission patternsMahdi Akbarzadeh, Parisa Riahi, Amir Hossein Saeidian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2011
Phase I trial of bortezomib (PS-341; NSC 681239) and alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory B-cell neoplasmsBeata Holkova, E Brent Perkins, Viswanathan Ramakrishnan, et al.
Leukemia & Lymphoma|August 19, 2015
Phase 1 trial of carfilzomib (PR-171) in combination with vorinostat (SAHA) in patients with relapsed or refractory B-cell lymphomasBeata Holkova, Maciej Kmieciak, Prithviraj Bose, et al.
Nature Materials|April 28, 2015
Spectroscopic evidence for negative electronic compressibility in a quasi-three-dimensional spin-orbit correlated metalJunfeng He, T Hogan, Thomas R Mion, et al.
Pageof 16

Showing results (141-150 of 153) with videos related to

Sort By:
Pageof 16
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 13, 2004
Preventing the spontaneous modification of an HLA-A2-restricted peptide at an N-terminal glutamine or an internal cysteine residue enhances peptide antigenicityLee W Thompson, Kevin T Hogan, Jennifer A Caldwell, et al.
Chempluschem|January 17, 2020
Synthesis of Oligo(1,8-pyrenylene)s: A Series of Functional Molecular LiquidsJoshua C Walsh, David T Hogan, Kerry-Lynn M Williams, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 9, 2008
A multipeptide vaccine is safe and elicits T-cell responses in participants with advanced stage ovarian cancerKimberly A Chianese-Bullock, William P Irvin, Gina R Petroni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Genomic organization, incidence, and localization of the SPAN-x family of cancer-testis antigens in melanoma tumors and cell linesV Anne Westbrook, Pamela D Schoppee, Alan B Diekman, et al.
Annals of Surgical Oncology|October 17, 2008
Evaluation of the sentinel immunized node for immune monitoring of cancer vaccinesCraig L Slingluff, Galina V Yamshchikov, Kevin T Hogan, et al.
Leukemia & Lymphoma|January 21, 2017
A phase 1 study of bortezomib and romidepsin in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma, indolent B-cell lymphoma, peripheral T-cell lymphoma, or cutaneous T-cell lymphomaBeata Holkova, Victor Yazbeck, Maciej Kmieciak, et al.
Scientific Reports|February 27, 2024
The Tehran longitudinal family-based cardiometabolic cohort study sheds new light on dyslipidemia transmission patternsMahdi Akbarzadeh, Parisa Riahi, Amir Hossein Saeidian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2011
Phase I trial of bortezomib (PS-341; NSC 681239) and alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory B-cell neoplasmsBeata Holkova, E Brent Perkins, Viswanathan Ramakrishnan, et al.
Leukemia & Lymphoma|August 19, 2015
Phase 1 trial of carfilzomib (PR-171) in combination with vorinostat (SAHA) in patients with relapsed or refractory B-cell lymphomasBeata Holkova, Maciej Kmieciak, Prithviraj Bose, et al.
Nature Materials|April 28, 2015
Spectroscopic evidence for negative electronic compressibility in a quasi-three-dimensional spin-orbit correlated metalJunfeng He, T Hogan, Thomas R Mion, et al.
Pageof 16